235 related articles for article (PubMed ID: 2805405)
21. Soluble interleukin-2 receptor in blood from patients with sarcoidosis and idiopathic pulmonary fibrosis.
Tsutsumi T; Nagai S; Imai K; Setoyama Y; Uchiyama T; Izumi T
Sarcoidosis; 1994 Sep; 11(2):102-9. PubMed ID: 7809492
[TBL] [Abstract][Full Text] [Related]
22. Soluble adhesion molecules and interleukin-2 receptor concentrations in patients with autoimmune chronic hepatitis.
Simpson KJ; Jones AL; Forbes Howie A; Hayes PC
Eur J Gastroenterol Hepatol; 1995 May; 7(5):455-60. PubMed ID: 7542148
[TBL] [Abstract][Full Text] [Related]
23. Monitoring soluble interleukin-2 receptor levels in related and unrelated donor allogenic bone marrow transplantation.
Foley R; Couban S; Walker I; Greene K; Chen CS; Messner H; Gauldie J
Bone Marrow Transplant; 1998 Apr; 21(8):769-73. PubMed ID: 9603399
[TBL] [Abstract][Full Text] [Related]
24. Cell-mediated immunity to gluten fraction III in adult coeliac disease.
Holmes GK; Asquith P; Cooke WT
Clin Exp Immunol; 1976 May; 24(2):259-65. PubMed ID: 1277578
[TBL] [Abstract][Full Text] [Related]
25. Clinical response to gluten withdrawal is not an indicator of coeliac disease.
Campanella J; Biagi F; Bianchi PI; Zanellati G; Marchese A; Corazza GR
Scand J Gastroenterol; 2008; 43(11):1311-4. PubMed ID: 18609173
[TBL] [Abstract][Full Text] [Related]
26. Aspirin reduces serum anti-melanocyte antibodies and soluble interleukin-2 receptors in vitiligo patients.
Zailaie MZ
Saudi Med J; 2005 Jul; 26(7):1085-91. PubMed ID: 16047057
[TBL] [Abstract][Full Text] [Related]
27. Clinical significance of serum levels of soluble interleukin-2 receptor in patients with localized scleroderma.
Ihn H; Sato S; Fujimoto M; Kikuchi K; Takehara K
Br J Dermatol; 1996 May; 134(5):843-7. PubMed ID: 8736323
[TBL] [Abstract][Full Text] [Related]
28. Serum soluble interleukin-2 receptor, soluble CD8 and soluble intercellular adhesion molecule-1 levels in Crohn's disease, celiac disease, and systemic lupus erythematosus.
Srivastava MD; Rossi TM; Lebenthal E
Res Commun Mol Pathol Pharmacol; 1995 Jan; 87(1):21-6. PubMed ID: 7735726
[TBL] [Abstract][Full Text] [Related]
29. Serum interleukin-2 and soluble interleukin-2 receptor in gestational trophoblastic diseases.
Shaarawy M; Darwish NA; Abdel-Aziz O
J Soc Gynecol Investig; 1996; 3(1):39-46. PubMed ID: 8796806
[TBL] [Abstract][Full Text] [Related]
30. Serum levels of soluble interleukin-2 receptor in patients with ANCA-associated vasculitis.
Arranz O; Ara J; Rodríguez R; Saurina A; Mirapeix E; Darnell A
J Nephrol; 2000; 13(1):59-64. PubMed ID: 10720216
[TBL] [Abstract][Full Text] [Related]
31. Changes in the levels of serum-soluble interleukin-2 receptor after surgical stress.
Murakami S; Sakata H; Tsuji Y; Okubo K; Takahashi T; Kikuchi M; Hirayama R
Surg Today; 2003; 33(8):565-70. PubMed ID: 12884092
[TBL] [Abstract][Full Text] [Related]
32. Positive skin reactions to gluten in coeliac disease.
Baker PG; Read AE
Q J Med; 1976 Oct; 45(180):603-10. PubMed ID: 137415
[TBL] [Abstract][Full Text] [Related]
33. Gluten-free diet may alleviate depressive and behavioural symptoms in adolescents with coeliac disease: a prospective follow-up case-series study.
Pynnönen PA; Isometsä ET; Verkasalo MA; Kähkönen SA; Sipilä I; Savilahti E; Aalberg VA
BMC Psychiatry; 2005 Mar; 5():14. PubMed ID: 15774013
[TBL] [Abstract][Full Text] [Related]
34. The soluble interleukin-2 receptor as a marker for human neoplasia and immune status.
Zerler B
Cancer Cells; 1991 Dec; 3(12):471-9. PubMed ID: 1820093
[TBL] [Abstract][Full Text] [Related]
35. Gluten-sensitive hypertransaminasemia in celiac disease: an infrequent and often subclinical finding.
Korpimäki S; Kaukinen K; Collin P; Haapala AM; Holm P; Laurila K; Kurppa K; Saavalainen P; Haimila K; Partanen J; Mäki M; Lähdeaho ML
Am J Gastroenterol; 2011 Sep; 106(9):1689-96. PubMed ID: 21502996
[TBL] [Abstract][Full Text] [Related]
36. Clinical response to cyclosporin in chronic severe asthma is associated with reduction in serum soluble interleukin-2 receptor concentrations.
Alexander AG; Barnes NC; Kay AB; Corrigan CJ
Eur Respir J; 1995 Apr; 8(4):574-8. PubMed ID: 7664856
[TBL] [Abstract][Full Text] [Related]
37. [Cellular sensitization against gluten in coeliac disease (author's transl)].
Stosiek P; Varga A
Dtsch Med Wochenschr; 1980 Jan; 105(3):88-91. PubMed ID: 6965369
[TBL] [Abstract][Full Text] [Related]
38. [The serum level of the secreted interleukin 2 receptor (sIL-2R): a lymphocyte activity parameter in sarcoidosis].
Müller-Quernheim J; Strausz J; Ferlinz R
Pneumologie; 1990 Feb; 44 Suppl 1():213-4. PubMed ID: 2367367
[TBL] [Abstract][Full Text] [Related]
39. Serum cytokines elevated during gluten-mediated cytokine release in coeliac disease.
Goel G; Daveson AJM; Hooi CE; Tye-Din JA; Wang S; Szymczak E; Williams LJ; Dzuris JL; Neff KM; Truitt KE; Anderson RP
Clin Exp Immunol; 2020 Jan; 199(1):68-78. PubMed ID: 31505020
[TBL] [Abstract][Full Text] [Related]
40. Cytophilic antibodies cause leucocyte migration inhibition in coeliac disease.
Corazza GR; Frisoni M; Mulè P; Prati C; Zoli G; Valentini RA; Gasbarrini G
J Clin Lab Immunol; 1989 Feb; 28(2):79-83. PubMed ID: 2746631
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
